[1]EuropeanJournalofMedicinalChemistry,1976,vol.11,p.567-570
30709-68-3
30709-69-4
1012881-39-8
1094230-05-3
933752-92-2
62657-87-8
30818-28-1 | 4-Chloro-2-hydroxybenzonitrile | AA0031B3 | MFCD00234255
1508-76-5 | 1-Pyrrolidinepropanol, α-cyclohexyl-α-phenyl-, hydrochloride (1:1) | AA0031O4 | MFCD00079236
3105-55-3 | Monosodium maleate trihydrate | AA0031Y5 | MFCD00070246
5809-23-4 | 2-(4-Diethylamino-2-hydroxybenzoyl)benzoic acid | AA00325U | MFCD00134669
22422-34-0 | (1R,2R,3S,5R)-(-)-2,3-Pinanediol | AA00328Q | MFCD09955216
142994-45-4 | Fmoc-D-3-pyridylalanine | AA0032BX | MFCD00080267
19132-06-0 | (2S,3S)-(+)-2,3-Butanediol | AA0032EW | MFCD00063648
95-50-1 | 1,2-Dichlorobenzene | AA0032HY | MFCD00000535
638-26-6 | 10-Hydroxyoctadecanoic acid | AA0032L4 | MFCD08693364
32337-97-6 | 1-Chloro-2-iodo-3-nitrobenzene | AA0032NU | MFCD08275977